Estrigenix Therapeutics, Inc.’s chief scientific officer, Karyn Frick PhD was recently featured in Center for Technology Commercialization talking about the process Estrigenix went through to receive Small Business Innovation Research (SBIR) Ready funding.
The SBIR Ready program provided feedback and reviewed multiple proposals from Estrigenix before giving Estrigenix the green light for the SBIR Ready funding. Frick offered advice to others hoping to participate in the SBIR Ready program, “Practice and persistence is key. Keep at it, keep seeking advice from mentors and keep seeing feedback from CTC on the proposal.”
Read the full article here, wisconsinctc.org/client-successes/estrigenix-therapeutics-inc/.